Found 29 matching trials
Immune Reconstitution of Immunosuppressed Sepsis Patients
PHASE2A multicenter, randomized, double-blinded, placebo-controlled study of two ...
Location
CHU LIMOGES Service de Réanimation
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE2This randomized phase II trial studies how well glycosylated recombinant hu...
Location
UC San Diego Moores Cancer Center
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy
PHASE1This study is designed to evaluate the safety of biological active dose of ...
Location
Kaohsiung Medical University Hospital
Study on Interleukin-7 (CYT107) in HIV Patients
PHASE2This study was designed to evaluate the pharmacokinetics of 20µg/kg/week of...
Location
University of Miami School of Medicine
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
PHASE2This is a Phase II multicenter, open-labeled, controlled, randomized study ...
Location
San Raffaele Scientific Institute
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
PHASE2The purpose of the study is to evaluate the impact of an immunotherapy by I...
Location
Centre Leon Berard
Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation
PHASE1Participant is being asked to take part in this study because participant r...
Location
Multiple Locations
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
PHASE2Background: Drugs given to treat cancer (chemotherapy) can weaken the human...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
PHASE1RATIONALE: Interleukin-7 may stimulate the white blood cells to kill tumor ...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
PHASE2Comparison of the effects of CYT107 vs Placebo administered IM at 10μg/kg t...
Location
University of Florida College of Medicine